Does ALEMTUZUMAB Cause Transplant failure? 84 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Transplant failure have been filed in association with ALEMTUZUMAB (Campath). This represents 0.6% of all adverse event reports for ALEMTUZUMAB.
84
Reports of Transplant failure with ALEMTUZUMAB
0.6%
of all ALEMTUZUMAB reports
23
Deaths
35
Hospitalizations
How Dangerous Is Transplant failure From ALEMTUZUMAB?
Of the 84 reports, 23 (27.4%) resulted in death, 35 (41.7%) required hospitalization, and 20 (23.8%) were considered life-threatening.
Is Transplant failure Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 84 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Transplant failure?
TACROLIMUS (559)
MYCOPHENOLATE MOFETIL (436)
CYCLOPHOSPHAMIDE (221)
FLUDARABINE (218)
PREDNISONE (182)
CYCLOSPORINE (180)
PREDNISOLONE (172)
BUSULFAN (147)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (113)
AUTOLOGOUS CULTURED CHONDROCYTES (108)
Which ALEMTUZUMAB Alternatives Have Lower Transplant failure Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET